Nephrology News

High weekly averages of moderate to vigorous physical activity, or MVPA, were associated with a reduced risk for progression to chronic kidney disease, according to researchers.

A 55-year-old man new to the area presents to the ED complaining of excruciating left flank pain that radiates into his scrotum. He noted blood in the urine this morning and became worried enough to seek emergency care.

Adding salt to food — even sometimes — was linked to an increased risk for chronic kidney disease, according to a study published in JAMA Network Open.

Elevated resting heart rate may be a novel risk factor for end-stage renal disease, independent from other traditional risk factors, according to a study published in the Journal of the American Heart Association.

SAN DIEGO — Patients with lupus who received sodium-glucose cotransporter-2 inhibitors demonstrated reduced risks for major adverse cardiovascular events and kidney disease, a speaker said at ACR Convergence 2023.

SAN DIEGO — Obinutuzumab use increases the chances of achieving complete renal response and lowers the risk for kidney-related events and time to flare in lupus nephritis, according to data presented at ACR Convergence 2023.

PHILADELPHIA — An increase in patient education about living organ donation did not result in improvements in changing patient views of pursuing organ transplantation, according to data presented at ASN Kidney Week.

Long-term voclosporin is safe and efficacious for the treatment of lupus nephritis over 3 years, according to data published in Arthritis & Rheumatology.

A woman diagnosed with schizophrenia and psychosis who was nonverbal and nonresponsive for 2 decades recently “woke” after treatment with pulse steroids and cyclophosphamide.

The FDA has cleared an investigational new drug application for AlloNK in combination with rituximab to treat systemic lupus erythematosus in patients with active lupus nephritis, according to a press release from Artiva Biotherapeutics.